The data shown below were compiled from readership statistics for 17 Mendeley readers of this research output. Click here to see the associated Mendeley record.
|Readers by professional status||Count||As %|
|Student > Ph. D. Student||2||12%|
|Professor > Associate Professor||2||12%|
|Student > Doctoral Student||1||6%|
|Readers by discipline||Count||As %|
|Medicine and Dentistry||7||41%|
|Agricultural and Biological Sciences||3||18%|
|Pharmacology, Toxicology and Pharmaceutical Science||2||12%|
Attention Score in Context
This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 April 2020.
All research outputs
of 22,962,258 outputs
Outputs from OncoTargets and therapy
of 2,946 outputs
Outputs of similar age
of 193,438 outputs
Outputs of similar age from OncoTargets and therapy
of 38 outputs
Altmetric has tracked 22,962,258 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,946 research outputs from this source. They receive a mean Attention Score of 2.6. This one has done well, scoring higher than 79% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 193,438 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.
We're also able to compare this research output to 38 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.